These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 1361845

  • 1. Erythropoietin associated hypertension among pediatric dialysis patients.
    Komatsu Y, Ito K.
    Adv Perit Dial; 1992; 8():448-52. PubMed ID: 1361845
    [Abstract] [Full Text] [Related]

  • 2. Once weekly subcutaneous administration of recombinant erythropoietin in children treated with CAPD.
    Goldraich I, Goldraich N.
    Adv Perit Dial; 1992; 8():440-3. PubMed ID: 1361843
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. One year experience with subcutaneous human erythropoietin in CAPD: correction of renal anemia and increased ultrafiltration.
    Lubrich-Birkner I, Schollmeyer P, Steinhauer HB.
    Adv Perit Dial; 1990; 6():302-7. PubMed ID: 1982833
    [Abstract] [Full Text] [Related]

  • 7. Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients.
    Velasquez MT, Lew SQ, von Albertini B, Mishkin GJ, Bosch JP.
    Clin Nephrol; 1997 Dec; 48(6):341-5. PubMed ID: 9438091
    [Abstract] [Full Text] [Related]

  • 8. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
    Raja R, Bloom E, Johnson R, Goldstein M.
    Adv Perit Dial; 1994 Dec; 10():135-8. PubMed ID: 7999811
    [Abstract] [Full Text] [Related]

  • 9. Iron dextran treatment in peritoneal dialysis patients on erythropoietin.
    Suh H, Wadhwa NK.
    Adv Perit Dial; 1992 Dec; 8():464-6. PubMed ID: 1361849
    [Abstract] [Full Text] [Related]

  • 10. Pediatric uses of recombinant human erythropoietin: the outlook in 1991.
    Alexander SR.
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):42-53. PubMed ID: 1928079
    [Abstract] [Full Text] [Related]

  • 11. Influence of recombinant human erythropoietin treatment on cortisol responses to insulin-induced hypoglycemia in CAPD patients.
    Díez JJ, Iglesias P, Sastre J, Gómez-Pan A, Selgas R, Romero JR, Méndez J.
    Adv Perit Dial; 1993 Oct; 9():336-41. PubMed ID: 8105958
    [Abstract] [Full Text] [Related]

  • 12. Subcutaneous recombinant human erythropoietin in patients on CAPD.
    Lye WC, Lee EJ.
    Adv Perit Dial; 1991 Oct; 7():285-7. PubMed ID: 1680447
    [Abstract] [Full Text] [Related]

  • 13. [Arterial hypertension in patients with chronic kidney insufficiency in hemodialysis with erythropoietin].
    Martins Prata M, Teixeira de Sousa F, Barbas J, Vinhaś J, Marques da Costa A.
    Rev Port Cardiol; 1990 Feb; 9(2):119-23. PubMed ID: 2346662
    [Abstract] [Full Text] [Related]

  • 14. Comparison of intramuscular versus subcutaneous erythropoietin for the treatment of anemia in CAPD patients.
    Abreo K, Lubom JA, Collier L, Fleming D, Work J.
    Adv Perit Dial; 1994 Feb; 10():124-8. PubMed ID: 7999809
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of hypertension induced by erythropoietin in patients on hemodialysis.
    Yamakado M, Umezu M, Nagano M, Tagawa H.
    Clin Invest Med; 1991 Dec; 14(6):623-9. PubMed ID: 1794212
    [Abstract] [Full Text] [Related]

  • 16. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF, Law CB, Ting SM, Li P, Lai KN.
    Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience].
    de Sousa FT, Prata MM, Barbas JV, dos Santos JP.
    Acta Med Port; 1990 Nov; 3(6):347-52. PubMed ID: 2089856
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.
    Raja R, Bloom E, Johnson R.
    Adv Perit Dial; 1993 Nov; 9():177-80. PubMed ID: 8105918
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of treating anemia in patients undergoing chronic dialysis with small doses of human recombinant erythropoietin].
    Marusza W, Matuszkiewicz-Rowińska J, Tomik Z, Andrzejewski A, Rokicka M, Paszkowska M, Drygieniec D, Bobilewicz D, Zawadzka M, Abbas-Fatah A.
    Pol Tyg Lek; 1995 Oct; 50(40-44):15-8, 31. PubMed ID: 8650050
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone and cortisol secretion before and after erythropoietin therapy in CAPD patients.
    Diez JJ, Iglesias P, Sastre J, Gomez-Pan A, Mendez J, Bajo MA, Selgas R.
    Adv Perit Dial; 1994 Oct; 10():275-81. PubMed ID: 7999845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.